Tamas Hickish

Tamas Hickish is a Consultant Medical Oncologist at Dorset Cancer Centre (Royal Bournemouth Hospital) and holds a Visiting Professor position at Bournemouth University. He also serves as Medical Director at iQHealth Tech, demonstrating his commitment to both clinical practice and academic advancement in oncology.

Dr. Hickish's research focuses on oncology, particularly breast cancer (triple-negative and HER2-positive subtypes) and colorectal cancer. His current projects include Point of Care testing using pin prick blood testing for neutrophil count monitoring in chemotherapy patients and exploring AI/Machine learning to analyze ECHO data in patients receiving Trastuzumab. His work emphasizes clinical trial design and implementation across various cancer types.

His publication record demonstrates consistent contributions to high-impact oncology journals including Nature, Lancet Oncology, JAMA Surgery, and Annals of Oncology. His research spans breast cancer, colorectal cancer, and other gastrointestinal malignancies, with frequent involvement in large international multicenter trials focused on chemotherapy optimization, targeted therapies, and biomarker development.

While specific awards aren't explicitly mentioned in the available information, his extensive publication record in top-tier journals and leadership roles in major clinical trials suggest significant recognition within the oncology community.

Dr. Hickish maintains active collaborations with numerous institutions globally, reflecting his standing in the international oncology research community. His work at iQHealth Tech as Medical Director indicates his interest in leveraging technology to improve cancer care delivery and patient outcomes.